Medicon Hellas S.A. (ATH:MEDIC)

Market Cap	10.30M
Revenue (ttm)	18.12M
Net Income (ttm)	1.37M
Shares Out	4.42M
EPS (ttm)	0.31
PE Ratio	7.84
Forward PE	n/a
Dividend	0.06 (2.58%)
Ex-Dividend Date	Jul 15, 2024

Volume	2,893
Average Volume	3,458
Open	2.380
Previous Close	2.380
Day's Range	2.300 - 2.400
52-Week Range	1.940 - 2.940
Beta	0.49
RSI	58.41
Earnings Date	Jul 30, 2025

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer system for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calib...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 157
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: MEDIC

Financial Performance

In 2024, Medicon Hellas's revenue was 18.12 million, an increase of 0.03% compared to the previous year's 18.12 million. Earnings were 1.37 million, an increase of 3.38%.